Cita APA

Nagaki, Y., Motoyama, S., Sato, Y., Wakita, A., Fujita, H., Sasaki, Y., . . . Minamiya, Y. (2021). SUV(max) reduction predicts long-term survival in patients of non-pCR both in the tumor and lymph nodes after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. World J Surg Oncol.

Chicago Style Citation

Nagaki, Yushi, Satoru Motoyama, Yusuke Sato, Akiyuki Wakita, Hiromu Fujita, Yoshihiro Sasaki, Kazuhiro Imai, i Yoshihiro Minamiya. "SUV(max) Reduction Predicts Long-term Survival in Patients of Non-pCR Both in the Tumor and Lymph Nodes After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma." World J Surg Oncol 2021.

Cita MLA

Nagaki, Yushi, et al. "SUV(max) Reduction Predicts Long-term Survival in Patients of Non-pCR Both in the Tumor and Lymph Nodes After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma." World J Surg Oncol 2021.